Literature DB >> 30059789

'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Molly Fox1.   

Abstract

Evolution by natural selection eliminates maladaptive traits from a species, and yet Alzheimer's Disease (AD) persists with rapidly increasing prevalence globally. This apparent paradox begs an explanation within the framework of evolutionary sciences. Here, I summarize and critique previously proposed theories to explain human susceptibility to AD, grouped into 8 distinct hypotheses based on the concepts of novel extension of the lifespan; lack of selective pressure during the post-reproductive phase; antagonistic pleiotropy; rapid brain evolution; delayed neuropathy by selection for grandmothering; novel alleles selected to delay neuropathy; by-product of selection against cardiovascular disease; and thrifty genotype. Subsequently, I describe a new hypothesis inspired by the concept of mismatched environments. Many of the factors that enhance AD risk today may have been absent or functioned differently before the modern era, potentially making AD a less common affliction for age-matched individuals before industrialization and for the majority of human history. Future research is needed to further explore whether changes in environments and lifestyles across human history moderate risk factors and susceptibility to AD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s Disease; Darwinian medicine; Dementia; Diseases of civilization; Evolutionary medicine; Mismatch

Mesh:

Year:  2018        PMID: 30059789      PMCID: PMC6195455          DOI: 10.1016/j.arr.2018.07.008

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  141 in total

Review 1.  How is Darwinian medicine useful?

Authors:  R M Nesse
Journal:  West J Med       Date:  2001-05

Review 2.  Aluminium in Alzheimer's disease: are we still at a crossroad?

Authors:  Veer Bala Gupta; S Anitha; M L Hegde; L Zecca; R M Garruto; R Ravid; S K Shankar; R Stein; P Shanmugavelu; K S Jagannatha Rao
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

3.  APOE distribution in world populations with new data from India and the UK.

Authors:  P P Singh; M Singh; S S Mastana
Journal:  Ann Hum Biol       Date:  2006 May-Jun       Impact factor: 1.533

4.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

Authors:  C J Pike
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

5.  Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury.

Authors:  J Garcia-Estrada; J A Del Rio; S Luquin; E Soriano; L M Garcia-Segura
Journal:  Brain Res       Date:  1993-11-19       Impact factor: 3.252

6.  The genetical evolution of social behaviour. I.

Authors:  W D Hamilton
Journal:  J Theor Biol       Date:  1964-07       Impact factor: 2.691

7.  Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden.

Authors:  Benjamin C Trumble; Jonathan Stieglitz; Aaron D Blackwell; Hooman Allayee; Bret Beheim; Caleb E Finch; Michael Gurven; Hillard Kaplan
Journal:  FASEB J       Date:  2016-12-28       Impact factor: 5.191

8.  Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group.

Authors:  G Siest; P Bertrand; B Qin; B Herbeth; J M Serot; L Masana; J Ribalta; A P Passmore; A Evans; M Ferrari; M Franceschi; J Shepherd; M Cuchel; U Beisiegel; K Zuchowsky; A S Rukavina; J Sertic; M Stojanov; V Kostic; A Mitrevski; V Petrova; C Sass; A Merched; J T Salonen; L Tiret; S Visvikis
Journal:  Clin Chem Lab Med       Date:  2000-08       Impact factor: 3.694

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women.

Authors:  Molly Fox; Carlo Berzuini; Leslie A Knapp
Journal:  Psychoneuroendocrinology       Date:  2013-09-01       Impact factor: 4.905

View more
  6 in total

1.  Protective Variants in Alzheimer's Disease.

Authors:  Shea J Andrews; Brian Fulton-Howard; Alison Goate
Journal:  Curr Genet Med Rep       Date:  2019-01-24

2.  Healthcare services relaxing natural selection may contribute to increase of dementia incidence.

Authors:  Wenpeng You; Renata Henneberg; Maciej Henneberg
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

Review 3.  Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective.

Authors:  Molly Fox; Delaney A Knorr; Kacey M Haptonstall
Journal:  Ann N Y Acad Sci       Date:  2019-06-10       Impact factor: 6.499

Review 4.  The 4 D's of Pellagra and Progress.

Authors:  Adrian C Williams; Lisa J Hill
Journal:  Int J Tryptophan Res       Date:  2020-04-16

5.  Evaluating the impact of physical frailty during ageing in wild chimpanzees (Pan troglodytes schweinfurthii).

Authors:  Melissa Emery Thompson; Zarin P Machanda; Stephanie A Fox; Kris H Sabbi; Emily Otali; Nicole Thompson González; Martin N Muller; Richard W Wrangham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-09-21       Impact factor: 6.671

6.  Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.

Authors:  Wenhao Wu; Xintong Liang; Guoquan Xie; Langdi Chen; Weixiong Liu; Guolin Luo; Peiquan Zhang; Lihong Yu; Xuehua Zheng; Hong Ji; Chao Zhang; Wei Yi
Journal:  Molecules       Date:  2018-10-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.